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(61%) underwent muscle flap cover of the FPV reconstruction. In-hospital/
30-day mortality was 5.4% (2 of 37); one from respiratory failure 20 days
postoperatively, and the second, a 93-year-old woman, after withdrawal of
care at 24 hours. No patients required fasciotomy, and five wound hemato-
mas required reoperation. Focal femoropopliteal vein thrombosis occurred
in five limbs. Over a mean follow-up of 2.5 years (range, 0.03-13.3) 11
patients died of unrelated causes at a mean of 3.7 years (range, 0.2-10.6
years). Graft reintervention was required in seven patients during follow-up
for graft thromboses (n  2) stenoses (n  2), and anastomotic false
aneurysms (n  3). Apart from the latter, there was no other suggestion of
graft reinfection in any patient. Major limb loss occurred in one patient at 6
months despite a patent graft. Long-term FPV harvest morbidity included
mild leg swelling in 10 patients.
Conclusions: Replacement of infected synthetic grafts/femoral arter-
ies in the groin with FPV is safe and results in excellent limb preservation and
freedom from reinfection. FPV should be considered the preferred conduit
in good-risk patients with infection limited to the groin.
Secondary Interventions After Elective Thoracic Endovascular Aortic
Repair (TEVAR) for Degenerative Aneurysms: Incidence and
Outcomes
Cheong J. Lee, MD, Heron E. Rodriguez, MD, S. Chris Malaisrie, MD,
Melina R. Kibbe, MD, and Mark K. Eskandari, MD. Division of Vascular
Surgery and Cardiothoracic Surgery, Northwestern University, Chicago, Ill
Objectives: We assessed the incidence and outcomes of secondary
interventions (SI) after elective thoracic endovascular aortic repair (TEVAR)
for aneurysmal disease.
Methods:An institutional review of TEVAR performed for descending
thoracic aneurysms (DTAA) between 2000 and 2011 was performed from a
prospectively maintained database. Only elective cases of TEVAR for DTAA
using commercially available endografts were selected. The incidence of
unplanned graft-related SI (ie, open conversion or proximal or distal exten-
sions) was examined. Outcomes of each SI were then analyzed.
Results:We identified 83 patients who underwent elective TEVAR for
DTAA. Eight patients (9.52%) subsequently required graft-related SIs. The
mean interval to SI was 31.8 months. Patients who required SI were
significantly younger than patients who did not require SI (mean age,
57.5 11.6 vs 69.3 11.4 years, P .05). Endoleak was themost common
indication for SI: five patients (62.5%) underwent SI for a type I endoleak (4
type IA, 1 type IB), one for aneurysmal progression without endoleak, one
for type II endoleak, and 1 for type III endoleak. In the SI group, two
patients (25%) required open conversion, five (62.5%) required secondary
TEVAR (3 proximal and 1 distal extensions, and 1 relining), and 1 required
endovascular coiling only. In the SI group, clinically relevant perioperative
events occurred in three patients with one stroke (12.5%) and two access
complications (25%). Operative mortality (30 day) was zero with one
aneurysm-related late death occurring at 2 years after SI. Factors that
predispose the need for SI were fusiform morphology of the aneurysm (P
.05) and extent of graft coverage in the proximal landing zone (P  .05).
Size of the aneurysm treated and the type of device used were not significant
factors leading to SI.
Conclusions: Short-term and midterm results of elective TEVAR for
DTAA demonstrate good durability with acceptable rates of graft-related SI.
All currently available commercial endografts seem to perform equally in this
setting. Age, fusiform aneurysm morphology, and extent of proximal land-
ing zones were significant factors that led to subsequent SI. When SI is
necessary, most issues can be resolved via endovascular means. Conversion
to open repair, however, is not insignificant and may lead to increased
operative morbidity.
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Objectives: Intuitively, patients with aortic aneurysms represent a
high-risk population for the development of a variety of tumors. We sought
to identify the incidence and pattern of new cancer diagnoses in a cohort
after endovascular aneurysm repair (EVAR), and to determine the rate with
which these diagnoses were obtained by surveillance computed tomography
angiogram (CTA).
Methods: A prospective cohort of 331 patients undergoing endovas-
cular exclusion of 286 abdominal aortic aneurysms, 31 thoracoabdominal
and descending thoracic aortic aneurysms, and 14 isolated common iliac
artery aneurysms between 1997 and 2009 was analyzed. We identified all
patients diagnosed with new thoracic and abdominal tumors in addition to
leukemia and lymphoma.
Results: Of this cohort, 193 patients (58%) carried a preoperative
history of malignancy. The most common tumors encountered included
prostate (n  28), lung (n  14), and breast (n  10). During a median
follow-up of 37 months, 29 patients (8.7%) developed 31 tumors. Thirteen
of these tumors (45%) included newly diagnosed lung cancers in addition to
renal cell carcinoma (n  3), colon cancer (n  2), prostate cancer (n  2),
and lymphoma (n  2). Sixteen of these tumors (55%) were identified on
post-EVAR surveillance CTA. The most common tumor encountered on
post-EVAR surveillance CT was lung cancer (n  7), 80% of which were
stage I or “limited” at the time of diagnosis; all renal cell carcinomas (n 3)
were identified in this fashion. Mean interval to diagnosis after EVAR was
31.3 months.
Conclusions: Compared with the general population, patients with
aortic aneurysms carry a heightened risk of cancer development. Serial CT
scans for post-EVAR surveillance may reveal a high rate of malignancy in this
population, such that vascular surgeons should remain observant and pre-
pared to arrange for the appropriate oncologic follow-up. It seems possible
that post-EVAR surveillance may allow for earlier cancer detection, and an
effort to further identify whether this early detection offers a clinical or
survival benefit is warranted.
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Objectives: Published literature on postoperative outcomes after aortic
surgery for prosthetic aortic graft infection (AGI) is limited by relatively
small sample sizes resulting in lack of national benchmarks for quality of care.
We report in-hospital outcomes after aortic surgery for AGI and identify
factors associated with postoperative complications using the Nationwide
Inpatient Sample (NIS) database.
Methods: Patients who underwent aortic graft resection for AGI were
identified from the 2002 to 2008 NIS database, a multicenter database
capturing 20% of all United States admissions. Multivariable logistic regres-
sion analyses were performed.
Results: In 394 patients (73.4% men) who underwent aortic surgery
for AGI, median age was 72 years. Fifty-three percent of the admissions were
emergent or urgent. Median hospital volume of aortic surgery for AGI
during the study period was one case. A significant trend for decreasing
number of AGIs per year was observed during the study span (Pearson’s
correlation r	0.96; P .0006). During the same time span, a significant
correlation was also seen with decrease in open, and increase in endovascular
aortic aneurysm repairs in the NIS database (Fig). In-hospital rates of overall
postoperative morbidity and mortality were 68.3% and 19.8%, respectively.
In-hospital rates of postoperative respiratory failure, renal failure, and cardiac
arrest were 35.5%, 14.2%, and 8.9%, respectively. Median length of stay was
26 days, with median hospital charges being $184,162. On multivariable
analysis, increase in age per year (odds ratio, 1.07; 95% confidence interval,
1.03-1.12) was independently associated with postoperative morbidity,
whereas higher hospital volume for this procedure was protective (odds
ratio, 0.71; 95% confidence interval, 0.56-0.89). On multivariable analysis,
Fig.
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